217 related articles for article (PubMed ID: 26200801)
1. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J
Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801
[No Abstract] [Full Text] [Related]
2. A severe anti MDA-5 antibodies associated amyopathic dermatomyositis.
El Euch M; Bani W; Mahfoudhi M; Jaziri F; Ben Abdelghani K; Turki S; Ben Abdallah T
Tunis Med; 2017 Jun; 95(6):444-445. PubMed ID: 29512806
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease.
Miyake M; Sakai A; Nishijima C; Kita T; Nitta E; Kawashima A; Hamaguchi Y; Fujimoto M; Inaoki M
J Dermatol; 2014 Jul; 41(7):664-5. PubMed ID: 24930560
[No Abstract] [Full Text] [Related]
4. Anti-MDA-5-positive dermatomyositis associated rapidly progressive interstitial lung disease, a virus-triggered autoimmune-like symptom?
Xu L; Wang L; Lv C; Tan W
Rheumatology (Oxford); 2021 Sep; 60(9):4428-4429. PubMed ID: 33752230
[No Abstract] [Full Text] [Related]
5. Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.
Nandy A; Gaïni S; Sore P
Scand J Rheumatol; 2018 Jul; 47(4):334-335. PubMed ID: 29043891
[No Abstract] [Full Text] [Related]
6. Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis.
Zhang X; Zhou S; Wu C; Li M; Wang Q; Zhao Y; Zeng X
Rheumatology (Oxford); 2021 Jul; 60(7):e227-e228. PubMed ID: 33410494
[No Abstract] [Full Text] [Related]
7. A case of simultaneous onset of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis accompanied by interstitial pneumonia and pulmonary tuberculosis.
Fujimoto S; Saito K; Kuwano K
Int J Rheum Dis; 2020 Feb; 23(2):273-275. PubMed ID: 31916372
[No Abstract] [Full Text] [Related]
8. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
[TBL] [Abstract][Full Text] [Related]
9. Inverse Gottron's Sign in A Patient With Anti-MDA5 Associated Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
Lee HJ; Feng A; Huan NC
Am J Med Sci; 2021 Oct; 362(4):e35. PubMed ID: 33582154
[No Abstract] [Full Text] [Related]
10. Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies.
Leclair V; Labirua-Iturburu A; Lundberg IE
J Rheumatol; 2018 Apr; 45(4):581-583. PubMed ID: 29606647
[No Abstract] [Full Text] [Related]
11. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.
Tanaka N; Terao C; Nakayama Y; Sasai T; Umezawa N; Yagyu Y; Ito K; Koike R; Nakashima R; Hatta K; Mizoguchi F
Rheumatology (Oxford); 2021 Mar; 60(3):e104-e106. PubMed ID: 33097938
[No Abstract] [Full Text] [Related]
12. [The Diagnosis is Obvious].
Fisser C; Wiest C; Hamer OW; Müller T; Lubnow M; Pfeifer M; Lerzer C; Dvorak I
Pneumologie; 2020 Nov; 74(11):780-786. PubMed ID: 32663889
[TBL] [Abstract][Full Text] [Related]
13. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.
Yamaoka T; Doi C; Yokomi A; Tanemura A; Murota H; Tani M; Saruban H; Hamaguchi Y; Fujimoto M; Katayama I
Eur J Dermatol; 2014; 24(4):490-1. PubMed ID: 25075604
[No Abstract] [Full Text] [Related]
14. The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.
Osawa T; Morimoto K; Sasaki Y; Matsuda S; Yamana K; Yano R; Uchiyama T; Goto H
Intern Med; 2018 Feb; 57(3):387-391. PubMed ID: 29093381
[TBL] [Abstract][Full Text] [Related]
15. Unusual cutaneous manifestation of dermatomyositis.
Chan WSA; Lee JS; Ng SK; Oon HHB
Australas J Dermatol; 2018 Aug; 59(3):e228-e230. PubMed ID: 29231237
[No Abstract] [Full Text] [Related]
16. Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies.
Sato S; Kuwana M; Fujita T; Suzuki Y
Mod Rheumatol; 2012 Aug; 22(4):625-9. PubMed ID: 22124544
[TBL] [Abstract][Full Text] [Related]
17. Rapid increase of serum anti-MDA-5 antibodies and exacerbation of clinically amyopathic dermatomyositis/interstitial lung disease.
Murase C; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e43-e44. PubMed ID: 27027846
[No Abstract] [Full Text] [Related]
18. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
[TBL] [Abstract][Full Text] [Related]
19. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
[TBL] [Abstract][Full Text] [Related]
20. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
